The Temple secondary sale has propelled the healthtech startup to a $375 million valuation — nearly double its previous mark — as publicly reported on 2026-07-28. Healthtech startup Temple, founded by Deepinder Goyal, has doubled its valuation to $375 million following a secondary share sale and has launched its first employee stock ownership plan (ESOP) liquidity programme. The deal underscores surging investor confidence in Temple’s vision for real-time metabolic wearables, even before its product reaches full commercial scale.
Quick Highlights
- Founder: Deepinder Goyal
- Round: Secondary Sale
- Valuation (Post-Transaction): $375 million
- Previous Valuation: ~$190 million
- Sector: Health Tech / Wearables
- Headquarters: India
- Announcement Date: 28 July 2026
Funding Breakdown
Use of Funds
Alongside its valuation jump, Temple has introduced its first ESOP liquidity programme, allowing employees to monetise a part of their stock options. Around 20 employees from Temple’s workforce of 200–220 will be eligible to sell up to 25% of their vested ESOPs under the programme. The secondary transaction itself does not inject fresh primary capital into the company; rather, it establishes a new price anchor for existing shares while rewarding early team members.
Funding Timeline
The buyback values the startup at $375 million, nearly double the $190 million valuation at which it raised a $54 million seed funding round in February 2026. Temple raised $54 million earlier this year from Steadview Capital, Peak XV Partners, Vy Capital and Info Edge, alongside several founder-investors and early employees. Regulatory filings show Deepinder Goyal owns around 28% of Temple, while employees collectively hold about 10% through ESOPs; among institutional investors, Steadview Capital is the largest shareholder with a stake of just over 5%, followed by Peak XV Partners, which owns slightly more than 3%.
Expansion Plans
Founded by Goyal after he stepped down as CEO of Eternal, Temple is focused on wearable technology for health and wellness, and the company has been expanding its team and product development efforts ahead of a broader commercial rollout. Temple is developing a forehead-worn wearable device designed to measure the body’s metabolic state in real time; the device, currently available in early access, is positioned as a wellness product and is expected to launch commercially within the next year, subject to further validation and product development. The startup has partnered with Ethereal Machines and Zetwerk for manufacturing. Temple is also seeking new funding at a valuation of approximately $500 million and has set the price of its first wearable gadget at around ₹80,000.
Significance
Temple’s latest valuation milestone and employee-focused initiative reflect growing investor confidence in India’s emerging healthtech sector, while reinforcing the increasing importance of employee ownership in the country’s startup ecosystem. The move comes as Temple prepares for its commercial launch and attracts growing investor interest ahead of its next fundraising round. The ESOP programme places Temple among a growing number of Indian startups offering wealth-creation opportunities to their teams; nine startups have collectively completed ESOP buybacks worth more than $270 million in 2026 so far. For a pre-revenue wearable startup, a 2× valuation step-up via secondary activity alone signals that secondary markets are increasingly being used to validate price discovery — and retain talent — ahead of formal Series A rounds.
These details have been verified against multiple publicly available reports as of 2026-07-28.
Stay updated with the latest startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
